Trials / Completed
CompletedNCT01825551
The Effect of GCSF in the Treatment of ALS Patients
The Effect of Granulocyte Colony Stimulating Factor (GCSF) in the Treatment of Amyotrophic Lateral Sclerosis (ALS) Patients Referred to Tehran Imam Khomeini and Shariati Hospital Centers in 2013
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Tehran University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the effect off Granulocyte Colony Stimulating Factor (GCSF) in the treatment of Amyotrophic Lateral Sclerosis (ALS) patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Granulocyte Colony Stimulating Factor | |
| DRUG | Placebo |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2013-04-05
- Last updated
- 2013-11-13
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT01825551. Inclusion in this directory is not an endorsement.